284,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
142 °P sammeln
  • Gebundenes Buch

This book presents a review of a rapidly developing field of viral nanotechnology in the context of immunology, virology, microbiology, chemistry, physics, and mathematical modeling. Viral nanotechnology is founded on the unexpected properties of viral nanoparticles. It emphasizes applications of viral nanotechnology to improving health and advancing material technologies. These applications include developing vaccines for prevention of disease, developing drugs and genetic therapies for treatment of disease, and developing diagnostic reagents and novel imaging technologies for detecting disease and infectious agents causing disease.…mehr

Produktbeschreibung
This book presents a review of a rapidly developing field of viral nanotechnology in the context of immunology, virology, microbiology, chemistry, physics, and mathematical modeling. Viral nanotechnology is founded on the unexpected properties of viral nanoparticles. It emphasizes applications of viral nanotechnology to improving health and advancing material technologies. These applications include developing vaccines for prevention of disease, developing drugs and genetic therapies for treatment of disease, and developing diagnostic reagents and novel imaging technologies for detecting disease and infectious agents causing disease.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Yury Khudyakov, PhD, received his MS in genetics from Novosibirsk State University and his PhD in molecular biology from the D.I. Ivanovsky Institute of Virology, Academy of Medical Sciences in Russia. He is chief of the Molecular Epidemiology and Bioinformatics Laboratory, Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia. He has published more than 170 research papers and book chapters, is an author of several issued and pending patents, and is a member of the editorial board for the Journal of Clinical Virology and academic editor for PlosOne. Paul Pumpens graduated from the Chemical Department of the University of Latvia in 1970, received his PhD in molecular biology from the Latvian Academy of Sciences in Riga, and received his DSc from the Institute of Molecular Biology of the USSR Academy of Sciences in Moscow. He pioneered genetic engineering research in Latvia and was one of the first in the world to successfully clone the hepatitis B virus genome. He is an author of more than 300 scientific papers and issued or pending patents.